Table 1 Patient demographics and clinical characteristics
From: Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study
Characteristic | n = 36 |
|---|---|
Age, years, median (range) | 16 (14–17) |
Sex | |
Male, n (%) | 25 (69.4) |
Female, n (%) | 11 (30.6) |
Organ involvement | |
SS-s, n (%) | 10 (27.8) |
SS-p, n (%) | 2 (5.6) |
SS-m, n (%) | 5 (13.9) |
MS, n (%) | 19 (52.8) |
SS-s organ involvement (n = 10) | |
Bone, n (%) | 4 (40.0) |
Pituitary, n (%) | 3 (30.0) |
Lymph node, n (%) | 2 (20.0) |
Soft tissue, n (%) | 1 (10.0) |
MS organ involvement (n = 19) | |
Pituitary, n (%) | 15 (78.9) |
Bone, n (%) | 8 (42.1) |
Lung, n (%) | 8 (42.1) |
Lymph node, n (%) | 8 (42.1) |
Liver, n (%) | 6 (31.6) |
Spleen, n (%) | 6 (31.6) |
Thyroid, n (%) | 5 (26.3) |
Skin, n (%) | 3 (15.8) |
Risk organ, n (%) | 8 (42.1) |